Chiesi Group

We are delighted to announce that Roch Doliveux, Paolo Pucci and Daphne Quimi have been appointed as new independent non-executive directors to Chiesi Group’s Board.   Each appointment brings heavyweight experience in managing healthcare delivery across key international markets, including the United States.    The addition of three non-executive directors marks a significant part for Chiesi’s broader strategy to enhance the Board’s capabilities, focusing on both upskilling and diversifying our leadership internationally.    Welcome on board!    #ChiesiGroup

The impact of #RareDiseases is more than you can imagine. On #RareDiseaseDay, we come together with the global rare disease community connected by a shared purpose: creating meaningful change. By truly listening, building connections and amplifying the voice of the community, we can shape a future that reflects the needs and insights of those living with rare diseases. Learn more on www.rarediseaseday.org EURORDIS-Rare Diseases Europe Rare Disease Day #ChiesiGroup #ChiesiGlobalRareDiseases

At Chiesi, we prioritize sustainability and inclusivity across our entire value chain. Our updated Code of Interdependence, serving as the Group’s Value Chain Code of Conduct, incorporates feedback from Chiesi departments and partners, ensuring it remains relevant and effective. This update reflects changes in internal policies, practices, procedures, and relevant regulations, marking a significant step forward in our journey towards a more sustainable and inclusive future.  Learn more here: https://lnkd.in/ddYU7CzJ

#RareDiseases present unique challenges that demand attention and collective action. At Chiesi, we’re driving health innovation to accelerate scientific breakthroughs, speed up diagnosis, and ensure equitable access to treatments. Promoting investment and research is essential to turn scientific challenges into opportunities and create a supportive environment for those living with rare diseases across the EU and beyond. With the establishment of our new Biotech Center of Excellence in Parma, Italy, we have shown that pioneering biotech innovations can thrive right here in Europe. Read the full article here: https://lnkd.in/eZDYZAbQ #ChiesiGroup #ChiesiGlobalRareDiseases

99% of the world’s population breathes air that exceeds safe limits, leading to 7 million premature deaths each year. At Chiesi, we believe that clean air is a basic right for all. That is why today, for #WorldDayofSocialJustice, we’re proud to announce that we are joining Alliance for Clean Air, a global movement bringing companies together to measure, reduce, and fight air pollution while advancing climate action. Through our #ActionOverWords campaign, we are committed to taking concrete actions to create a more sustainable future and improve health for all. Learn how business leaders are measuring and reducing #airpollutants coming from their operations and value chains. Discover more about our approach: https://lnkd.in/d-fXspZ Clean Air Fund World Economic Forum (WEF) SEI — Stockholm Environment Institute #ChiesiGroup #AllianceForCleanAir #NetZero

We are proud to share that our CEO, Giuseppe Accogli, recently participated in a high-level meeting with Spain's Prime Minister Pedro Sánchez, Health Minister Mónica García, Industry and Tourism Minister Jordi Hereu, and Secretary of State for Science, Innovation, and Universities Juan Cruz Cigudosa.   This gathering brought together key representatives from the national, European, and international pharmaceutical industries to discuss strengthening public-private dialogue, driving innovation, and ensuring a predictable regulatory framework to enhance competitiveness and strategic autonomy within the #EU pharmaceutical sector.   Learn more 👇 #ChiesiGroup EFPIA - European Federation of Pharmaceutical Industries and Associations FARMAINDUSTRIA Chiesi España

The concept of rarity can be perceived in many ways. Living with a rare disease like #Fabry disease can impact people’s lives in many different ways, often bringing uncertainty and fear. However, as Ria reminds us, asking for help is always a good way to start. Facing a rare disease doesn't necessarily imply isolation. Instead, we can choose to view uniqueness as a form of richness. Explore Ria's story at www.itsrareforme.com #ChiesiGroup #ItsRareForMe #ChiesiGlobalRareDiseases

Did you know one of our first team members with an academic title was a woman? In 1936, Neive Terzi became the first woman with a degree to join Chiesi, just a year after the company's founding. At that time, the University of Parma was a beacon of progress, attracting female students from all over Italy. In 1932, out of 27 graduates in Medicine and Surgery, 12 were women. Neive Terzi laid the foundation for a journey of women empowerment that has become deeply ingrained in Chiesi's DNA, especially in the Research and Development department, where nowadays 66.7% of our researchers are women. These numbers reflect Chiesi’s commitment to empowering women in science and healthcare. #ChiesiGroup #WomenInScience #InternationalDayofWomenandGirlsinScience

"Do Good. Do Well. Repeat." isn't just a motto, it's our commitment to creating shared value.   What do we mean by shared value? It means that our growth benefits everyone - our business, our collaborators, and our community.   How do we achieve this? Through innovation, we address the challenges of our time and contribute to societal progress. This fuels both our financial sustainability and long-term growth, empowering us to reinvest in our business to create a lasting cycle of positive change.   Stay tuned to follow our journey in creating shared value for all.   #ChiesiGroup #DoGoodDoWellRepeat

We’re proud to be part of the change with IHI READI! By bringing together universities, pharmaceutical companies, regulatory bodies, and patient associations, the #READI (Research Europe and Diversity Inclusion) project aims to enhance the representativeness of underserved populations in #clinicalstudies in Europe by fostering a more cohesive and integrated clinical study ecosystem. At Chiesi, we’re dedicated to advancing clinical trials that truly reflect the diversity of patients. Through this initiative, we aim to: •Champion #diversity by designing trials that meet the needs of all patients. •Collaborate with partners to overcome representation challenges. •Contribute to patient-focused pharmaceutical research. Europe has the power to drive meaningful change—but success depends on collaboration and strong networks. Together, we can contribute to science innovation and promote health equity, by ensuring inclusive participation in clinical trial research. #HealthEquity #ClinicalResearch #READIProject